For a patient on semaglutide, an empty stomach can sometimes exacerbate nausea
Seek urgent medical attention (call 999 or go to A&E) if you experience: Severe or persistent vomiting, or inability to keep fluids down for more than 24 hours Severe upper abdominal pain, particularly if it radiates to the back (possible pancreatitis) Severe right-sided upper abdominal pain, with or without fever or yellowing of the skin or eyes (possible gallbladder problems a recognised class signal with GLP-1 receptor agonists) [14] [15] Contact NHS 111 or your GP if you experience: Fast, irregular heartbeat or palpitations Symptoms of hypoglycaemia (shakiness, sweating, confusion), particularly if taking insulin or other glucose-lowering medicines Dizziness or signs of dehydration (reduced urine output, dry mouth, light-headedness) If you think you have experienced a side effect from any medicine, you can report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app
Who are GLP-1 Users
doi: 10.21873/anticanres.11918 129 LogozziMDe MilitoALuginiLBorghiMCalabrLSpadaMet al
Retatrutide dosing schedule The retatrutide dosing protocol from clinical trials follows a similar but slightly different titration pattern: Week 1-4: 1-2 mg once weekly (starting dose varies by protocol) Week 5-8: 4 mg once weekly Week 9-12: 8 mg once weekly Week 13+: 12 mg once weekly (maximum dose) The dose increases are larger and less granular than Mounjaro
The scores were significant difference in each two groups compared by Games-Howell